We last reviewed the charts of Perrigo Corp. (PRGO) on April 9, 2020. We wrote that "After dealing with a drug recall fiasco two years ago I cannot wait for drugs and supplements to be made in the U.S. again. I guess I have some skin in the game when I look at PRGO. Traders could approach the long side of PRGO at current levels, risking a close below $41. Our initial upside price target is $56."
More from Stocks
Here's how traders can smartly play the restaurant chain
Is McDonald's okay in a recession? I would like to see that debt load reduced.
There has been a lack of overbuilding in the housing market and inventories remain low.